Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
The purpose of this study is to test the safety of different amounts (doses) of external radiation therapy (high-energy x-rays that shrink or destroy cancer) combined with chemotherapy.
Bladder Cancer
OTHER: external radiation therapy with gemcitabine
To determine the dose limiting toxicity and establish the maximal tolerated dose, 2 years
To determine the complete response rate of the primary tumor, 4-6 weeks following consolidation therapy|To determine the long term toxicity, 2 years
The purpose of this study is to test the safety of different amounts (doses) of external radiation therapy (high-energy x-rays that shrink or destroy cancer) combined with chemotherapy.